Speciality News

Little benefit was seen after implementing a bundle of interventions aimed at reducing hemodialysis catheter-related bloodstream infection (HD-CRBSI), the REDUCCTION trial found. In a large study of central venous hemodialysis catheter outcomes, implementing a suite of interventions at the renal service levels yielded a similar rate of bloodstream infections (rate ratio 1.30, 95% CI 0.78-2.16,
0 Comments
Months after he first developed COVID-19 symptoms in March, Paul Garner, MD, of Liverpool School of Tropical Medicine in England, still feels the effects of the disease. Garner, who is also a coordinating editor of the Cochrane Infectious Diseases group, describes ongoing symptoms like “difficulty reading — this is there all the time. I cannot
0 Comments
What is COVID brain fog? Judith Graham describes the sudden emergence of cognitive dysfunction in seniors who have become seriously ill from coronavirus ~ Older COVID Patients Battle ‘Brain Fog,’ Weakness and Emotional Turmoil (Kaiser Health News) Two recent analyses reveal a steep decline in COVID-related deaths among hospitalized patients. Geoff Brumfiel explores what factors
0 Comments
Nurses in all specialties and areas will, at some point, work with patients who have Alzheimer’s disease or dementia. Because the disease impacts each person in a different way, caring for patients can be challenging. Cindy Keith, RN, BS, CDP, owner of M.I.N.D. in Memory Care, and author of Love, Laughter, & Mayhem – Caregiver
0 Comments
Studies served up a slew of data at the virtual TCT Connect conference on ditching aspirin sooner after ST-segment myocardial infarction (STEMI); stroke risk with different transcatheter aortic valves; real-world results with a mechanical thrombectomy device for pulmonary embolism (PE); and mitral valve repair in cardiogenic shock. TICO-STEMI Cutting aspirin from a ticagrelor (Brilinta)-based dual
0 Comments
Two things are true about COVID-19. First, there is no person who has all the answers. SARS-CoV-2 affects every aspect of human life, carries massive uncertainty, and there is no demigod amongst us who understands the disease and policy response fully. Second, despite this truth, many of us feel we know what’s best. We know
0 Comments
While 2020 has been fraught with uncertainty, at least one thing is quite evident: antitrust compliance remains a high priority of the Department of Justice, particularly within the realm of healthcare and board activities. Rulings in two recent cases — SmileDirectClub LLC v. Tanja D. Battle et al. and Lazarou et al. v. American Board
0 Comments
Adding nutritional supplements, and protein in particular, to the diet of patients on hemodialysis didn’t seem to bolster their mortality rates, a pragmatic trial found. In a cluster-randomized clinical trial of over 10,000 patients on hemodialysis, patients on an intensive oral nutritional supplement protocol had similar mortality rates compared with those on standard care (hazard
0 Comments
CDK4/6 inhibition before chemotherapy reduced the risk of severe neutropenia in patients with small cell lung cancer (SCLC), pooled data from three randomized trials showed. Among 242 patients with extensive-stage SCLC, 11.4% of those receiving trilaciclib prior to each chemotherapy infusion experienced severe neutropenia over the first four cycles of treatment, as compared to 52.9%
0 Comments
Note that some links may require registration or subscription. Thursday marked completion of enrollment in Moderna’s U.S. vaccine clinical trial: 30,000 participants have received their first shot. (The Washington Post) And once the coveted vaccine is ready for deployment, the CDC announced plans to monitor recipients with a mobile program. (CNN) As of 8:00 a.m.
0 Comments
COVID-19 vaccine safety, dueling efficacy standards, and representation of groups from racial and ethnic minorities to children drew focus Thursday at arguably the most watched FDA advisory committee meeting ever. The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) featured a brief appearance by Peter Marks, MD, PhD, director of the agency’s Center for
0 Comments